SCHEMBL19960269

SCHEMBL19960269

O=P(c1ccccc1)(c1ccccc1)c1ccc2c3cc4ccccc4cc3c3nc4ccc(-c5cccc6ccccc56)cc4n3c2c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.36
PPARA Q07869 8/20 0.36
FLT3 P36888 2/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PPARD Q03181 1/20 0.35
MCL1 Q07820 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
HPGD P15428 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
AHR P35869 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
BMX P51813 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960275 0.91 ALDH1A1 (0.38) CYP2C19HPGDALDH1A1KDM4EAHR
SCHEMBL19960259 0.91 ALDH1A1 (0.38) CYP2C19HPGDALDH1A1KDM4EAHR
SCHEMBL19960270 0.89 FLT3 (0.36) PPARGPPARAFLT3CYP2C9CYP2C19
SCHEMBL19960264 0.89 ALDH1A1 (0.34) HPGDALDH1A1KDM4EAHRKMT2A
SCHEMBL19960167 0.87 KDM4E (0.41) FLT3CYP2C19HPGDALDH1A1KDM4E
SCHEMBL19960119 0.86 KDM4E (0.39) CYP2C9CYP2C19HPGDALDH1A1KDM4E
SCHEMBL19960010 0.86 ALDH1A1 (0.41) CYP2C9CYP2C19HPGDALDH1A1KDM4E
SCHEMBL19960008 0.85 HPGD (0.37) HPGDALDH1A1KDM4EAHRKMT2A
SCHEMBL20090153 0.85 ALDH1A1 (0.44) FLT3CYP2C9CYP2C19HPGDALDH1A1
SCHEMBL14644083 0.85 ALDH1A1 (0.44) FLT3CYP2C9CYP2C19HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 PPARG 706/4885PPARA 1102/4885FLT3 1211/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 PPARG 706/4885PPARA 1102/4885FLT3 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.